Treatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directions.

Diabetologia · 2016 · PMC4861748 · PMID 27101131

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

of borderline significancep = 0.05actually significant

However, resolution of NASH was of borderline significance (36% vs 21%, p = 0.05 vs placebo) in contrast to the effect of pioglitazone in the same trial (47% vs 21%, p = 0.001 vs placebo) [ 49 ].

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.